The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma
IntroductionA variety of biomarkers are considered for diagnosis (e.g., β2-microgobulin, albumin, or LDH) and prognosis [e.g., cytogenetic aberrations detected by fluorescence in situ hybridization (FISH)] of multiple myeloma (MM). More recently, clonal evolution has been established as key. Little...
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Frontiers Media S.A.
2022-07-01
|
| 丛编: | Frontiers in Oncology |
| 主题: | |
| 在线阅读: | https://www.frontiersin.org/articles/10.3389/fonc.2022.919278/full |